Skip to content. | Skip to navigation

Personal tools

Home > Medical Center > Department Resources > Antimicrobial Stewardship > Clinical Practice Guidelines > Sepsis > Catheter Related Bloodstream Infection

protocol : Catheter Related Bloodstream Infection

File Attachment Downloads

view  |  PDF document icon CLABSI.pdf — PDF document, 195 KB (200246 bytes)


  1. content:

    Definitions: Infection that originates from or is related to a central venous catheter.

    Microbiology testing: Paired blood cultures, drawn from the catheter and a peripheral vein should be obtained prior to initiation of antimicrobial therapy. The line should be removed and catheter cultures should be performed when a catheter is removed for suspected CRBSI but should not otherwise be obtained routinely.

    LocationCommon microbiologyPreferred empiric therapyPotential alternativesComments
    All inpatient settings

    S. aureus

    coagulase-negative staphylococci

    Enterobacterales
    Klebsiella spp.
    E. coli
    Enterobacter spp.

    Pseudomonas aeruginosa
    Enterococci
    *Candida spp.

    cefepime 2g IV Q8H

    PLUS

    vancomycin

    meropenem 1g IV Q8H

    PLUS

    vancomycin

    *Empiric therapy targeting catheter-related candidemia may be appropriate for select patients with suspected line-associated sepsis and any of the following risk factors:

    • TPN
    • Prolonged broad-spectrum antibiotics
    • Hematologic malignancy or SCT
    • Solid organ transplant
    • Femoral catheterization
    • Candida colonization at multiple sites

    Suggest discussion with ID (PIC 1369 or 1205) or Antimicrobial Stewardship (PIC 1337).

    CONSIDER:
    *micafungin 100mg IV Q24H

    Dosing recommendations in renal insufficiency.

    UVA antibiograms.

    More detailed guidance can be found in practice guidelines from the IDSA